Plating of Ovarian Cancer Patient‐Derived Organoids for Viability Assay
2:58
Performing Viability Assay Using a Bioluminescence Plate Reader
4:19
Results: Effect of Platinum Chemotherapy on Ovarian Cancer Patient‐Derived Organoids
5:17
Conclusion
Transcript
This protocol describes a low cost method for performing drug viability assays using patient-derived ovarian cancer organoids. The main advantages of this technique are the use of low cost and readily available materials and lab equipment. This me
Sign in or start your free trial to access this content
We present a protocol that can be used to conduct therapeutic drug testing with patient-derived ovarian cancer organoids.